Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

675-nm diode laser as an adjuvant treatment for telogen effluvium: case series

675-nm diode laser seems to be a safe, well-tolerated, and potentially effective adjuvant therapy for TE. Controlled studies are needed to confirm efficacy and establish standardized protocols.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors retrospectively reviewed 13 patients with telogen effluvium treated at a laser center in Mexico with adjuvant 675-nm diode laser therapy. They report that most patients with a positive baseline pull test became negative at follow-up, and that pruritus and trichodynia improved in most symptomatic patients, with no adverse events. The authors state that controlled studies are needed to confirm efficacy.

Participants
13
Who or what was studied
Patients diagnosed with telogen effluvium at a dermatologic laser center in Mexico
Wavelengths
675 nm
Limits stated in the abstract
The study is a retrospective case series of only 13 patients without a control group, and the authors state that controlled studies are needed to confirm efficacy.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

Telogen effluvium (TE) is a diffuse, non-scarring alopecia that can have a significant impact on quality of life. Although often self-limited, many patients seek therapies that speed recovery. Photobiomodulatory benefits of the 675-nm diode laser are also well established in treating other hair disorders, but there is limited evidence in TE.

Methods

We performed a retrospective case series of 13 patients diagnosed with TE at a Dermatologic Laser Center in Mexico. The patients received adjuvant treatment with 675-nm diode laser therapy.

Results

Of the 13 patients, 69% had chronic TE. Among those with a positive baseline pull test, 72% became negative at follow-up. Pruritus improved in 83% of symptomatic patients, and trichodynia resolved in 75%. No adverse events occurred.

Conclusion

675-nm diode laser seems to be a safe, well-tolerated, and potentially effective adjuvant therapy for TE. Controlled studies are needed to confirm efficacy and establish standardized protocols.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Laser. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies